A Canadian company has developed first-of-their-kind cell therapies that will, they hope, treat conditions that now affect 1 in 3 Americans: pattern baldness, aging and sun-damaged skin, and chronic tendon degeneration.
from Forbes - Leadership http://ift.tt/2x2KNaH
No comments:
Post a Comment